Related Experiment Videos
Correlation between fasting glucose in the first trimester and glucose challenge test in the second
1Department of Obstetrics and Gynecology, Hebrew University, Hadassah Ein-Karem Medical Center, Jerusalem, Israel. shush@cc.huji.ac.il
Obstetrics and Gynecology
|April 16, 1998
Summary
Early pregnancy fasting glucose levels show a weak correlation with later glucose challenge test results. This suggests that routine first-trimester fasting glucose screening for gestational diabetes has no clinical benefit.
Area of Science:
- Obstetrics and Gynecology
- Endocrinology
- Maternal-Fetal Medicine
Background:
- Gestational diabetes mellitus (GDM) screening typically occurs in the second trimester.
- Early pregnancy glucose levels may offer predictive value for GDM.
- Assessing the correlation between first-trimester fasting glucose and second-trimester glucose challenge test (GCT) is crucial for optimizing screening protocols.
Purpose of the Study:
- To investigate the statistical correlation between first-trimester fasting plasma glucose (FPG) and second-trimester 50-g glucose challenge test (GCT) levels.
- To determine the clinical utility of early pregnancy FPG measurements in predicting GCT outcomes.
Main Methods:
- A cohort of 612 healthy pregnant women with singleton pregnancies were analyzed.
- Fasting plasma glucose was measured during the first trimester.
- A 50-g glucose challenge test was administered at 24-28 weeks' gestation in 425 women.
Main Results:
- The mean first-trimester FPG was 77.8 ± 9.7 mg/dL, and the mean 1-hour post-GCT level was 109.1 ± 29.8 mg/dL.
- A statistically significant but weak positive correlation (r=.26, P < .001) was observed between first-trimester FPG and second-trimester GCT levels.
- Linear regression analysis indicated a low explanatory power (r²=.10) for first-trimester FPG and maternal weight in predicting second-trimester GCT results.
Conclusions:
- The correlation between early pregnancy fasting glucose and the second-trimester glucose challenge test is low.
- Routine fasting glucose measurement in the first trimester does not provide significant clinical benefit for predicting gestational diabetes.
- Current GDM screening guidelines focusing on the second trimester remain appropriate.